Valeant Seeks Breathing Room From Lenders
Valeant Pharmaceuticals said Wednesday it will seek permission from its lenders to delay filing financial disclosures as well as other waivers in order to avoid possible defaults as the Canadian drugmaker...To view the full article, register now.
Already a subscriber? Click here to view full article